← All stocks

ACTUATE THERAPEUTICS, INC.

ACTU Net buying
CIK 0001652935 #4914 in the set updated 20 Sep 2026
Bought (120 mo)
$13.50M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.45M
$0.00 on a plan · $824.97K straight out of an exercise
Sold at will
$1.62M
1 of 11 sales
Net
+$11.05M
+$11.88M against sales at will

By person

5 insiders · 20 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bios Equity COF, LP entity
Director
$4.50M (3)
$224.99K (3) scheduled
+$4.28M
196,428
0.8180%
$1.14M
Fletcher Aaron G.L.
Director
$4.50M (3)
$224.99K (3) scheduled
+$4.28M
196,428
0.8180%
$1.14M
Kreis Leslie W.
Director
$4.50M (3)
$224.99K (3) scheduled
+$4.28M
196,428
0.8180%
$1.14M
THOMSON TODD S
Director
$1.77M (2)
−$1.77M
904,795
3.77%
$5.25M
SCHMITT DANIEL M
President, CEO and Director
301,716
1.26%
$1.75M
Insider
Date
Role
Action
Shares
Price
Amount
THOMSON TODD S
5 Jan 2026
Director
Sell indirect
280,000
$5.80
$1.62M
Fletcher Aaron G.L.
27 Jun 2025
Director
Buy indirect
71,428
$7.00
$500.00K
Kreis Leslie W.
27 Jun 2025
Director
Buy indirect
71,428
$7.00
$500.00K
Bios Equity COF, LP
27 Jun 2025
Director
Buy indirect
71,428
$7.00
$500.00K
Kreis Leslie W.
14 Aug 2024
10% owner
Sold after exercise indirect
2,324
$9.00
$20.92K
Kreis Leslie W.
14 Aug 2024
10% owner
Sold after exercise indirect
17,361
$9.00
$156.25K
Kreis Leslie W.
14 Aug 2024
10% owner
Sold after exercise indirect
5,314
$9.00
$47.83K
Kreis Leslie W.
14 Aug 2024
10% owner
Buy indirect
125,000
$8.00
$1.00M
Kreis Leslie W.
14 Aug 2024
10% owner
Buy indirect
375,000
$8.00
$3.00M
Fletcher Aaron G.L.
14 Aug 2024
Director
Sold after exercise indirect
2,324
$9.00
$20.92K
Fletcher Aaron G.L.
14 Aug 2024
Director
Sold after exercise indirect
17,361
$9.00
$156.25K
Fletcher Aaron G.L.
14 Aug 2024
Director
Sold after exercise indirect
5,314
$9.00
$47.83K
Fletcher Aaron G.L.
14 Aug 2024
Director
Buy indirect
125,000
$8.00
$1.00M
Fletcher Aaron G.L.
14 Aug 2024
Director
Buy indirect
375,000
$8.00
$3.00M
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
2,324
$9.00
$20.92K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
17,361
$9.00
$156.25K
Bios Equity COF, LP
14 Aug 2024
Director
Sold after exercise indirect
5,314
$9.00
$47.83K
Bios Equity COF, LP
14 Aug 2024
Director
Buy indirect
125,000
$8.00
$1.00M
Bios Equity COF, LP
14 Aug 2024
Director
Buy indirect
375,000
$8.00
$3.00M
THOMSON TODD S
14 Aug 2024
Director
Sold after exercise indirect
18,750
$8.00
$150.00K

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 10
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 31,648,232
History held since 14 Aug 2024